After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, NTLA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Intellia Therapeutics Inc is $748.43M. A total of 2.86 million shares were traded on the day, compared to an average of 3.42M shares.
In the most recent transaction, Clark Eliana sold 679 shares of NTLA for 8.99 per share on Mar 04 ’25. After the transaction, the EVP, Chief Technical Officer now owns 95,369 company shares. In a previous transaction on Mar 04 ’25, BASTA JAMES sold 2,572 shares at 8.99 per share. NTLA shares that EVP, General Counsel owns now total 111,925.
Among the insiders who sold shares, Bhanji Muna disposed of 265 shares on Jan 29 ’25 at a per-share price of $9.97. This resulted in the Director holding 19,468 shares of NTLA after the transaction. In another insider transaction, Dube Michael P sold 1,372 shares at $12.18 per share on Jan 03 ’25. Company shares held by the VP, Chief Accounting Officer now total 45,640.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NTLA has a high of $28.18 and a low of $5.90.
As of this writing, NTLA has an earnings estimate of -$1.27 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of -$0.89 per share and a lower estimate of -$1.49.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NTLA’s latest balance sheet shows that the firm has $748.69M in Cash & Short Term Investments as of fiscal 2021. There were $74.02M in debt and $125.83M in liabilities at the time. Its Book Value Per Share was $8.55, while its Total Shareholder’s Equity was $1.04B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTLA is Buy with a score of 4.27.
